eSET Plus Single Embryo Cryotransfer vs Double Embryo Transfer
eSET
Randomized Clinical Trial Comparing Elective Single Embryo Transfer Plus Single Embryo Cryotransfer vs Double Embryo Transfer
1 other identifier
interventional
194
1 country
1
Brief Summary
The purpose of this study is to determine whether a policy of elective single embryo transfer (eSET) plus single embryo cryotransfer is as effective as a double embryo transfer in terms of clinical pregnancy rate
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 24, 2013
CompletedFirst Posted
Study publicly available on registry
July 26, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedResults Posted
Study results publicly available
February 20, 2015
CompletedMay 16, 2024
May 1, 2024
3.9 years
July 24, 2013
February 3, 2015
May 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical Pregnancy Rate
A clinical pregnancy was defined by the presence of a gestational sac with heartbeat on transvaginal ultrasonography at the 7th weeks of pregnancy
Seven weeks after embryo transfer
Secondary Outcomes (1)
Multiple Pregnancy Rate
Seven weeks after embryo transfer
Other Outcomes (1)
Live Birth Delivery Rate
38 weeks after embryo transfer
Study Arms (2)
Elective single embryo transfer
EXPERIMENTALAfter the FIV/ICSI procedure, in this arm the embryo transfer would be of a single embryo followed by the cryotransfer or a single embryo in case of no fresh conception
Double embryo transfer
ACTIVE COMPARATORAfter the FIV/ICSI procedure, in this arm the embryo transfer woub be of two fresh embryos
Interventions
After the FIV/ICSI procedure, the embryo transfer in this arm would be of one embryo followed by the cryotransfer of one embryo in case of no conception in the fresh cycle.
After the FIV/ICSI procedure, the embryo transfer in this arm would be of two fresh embryos
Eligibility Criteria
You may qualify if:
- women less tan 38 years
- women Body Mass Index (BMI) between 19-39 kg/m2
- Follicle-Stimulating Hormone (FSH) \<15 mUI/mL on cycle third day
- First IVF/ICSI cycle or second after a positive pregnancy test in the first one
You may not qualify if:
- More tan five years of infertility
- Previous uterus surgery
- Uterus malformations
- More tan one miscarriage
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unidad de gestión clínica de ginecología y obstetricia. Instituto Biosanitario de Granada.Hospital Universitario Virgen de las Nieves
Granada, 18014, Spain
Related Publications (1)
Lopez-Regalado ML, Clavero A, Gonzalvo MC, Serrano M, Martinez L, Mozas J, Rodriguez-Serrano F, Fontes J, Castilla JA. Randomised clinical trial comparing elective single-embryo transfer followed by single-embryo cryotransfer versus double embryo transfer. Eur J Obstet Gynecol Reprod Biol. 2014 Jul;178:192-8. doi: 10.1016/j.ejogrb.2014.04.009. Epub 2014 Apr 19.
PMID: 24798072DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Our study could have been complemented by improved embryo selection, using a time-lapse system. Another limitation of our study is that after devitrification, blastocyst culture was not performed.
Results Point of Contact
- Title
- Dr. Ana Clavero
- Organization
- University Hospital Virgen de las Nieves
Study Officials
- PRINCIPAL INVESTIGATOR
Ana Clavero, PhD
Investigator and laboratory specialist
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD MD
Study Record Dates
First Submitted
July 24, 2013
First Posted
July 26, 2013
Study Start
January 1, 2010
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
May 16, 2024
Results First Posted
February 20, 2015
Record last verified: 2024-05